LUV
45
-2
WAT
31
-2
AIZ
59
5
GRMN
71
22
NTAP
56
-4
RL
70
-3
PWR
60
-3
PYPL
41
-8
IVZ
52
-3
SLG
67
-3
SE
52
-2
BK
71
-3
RIG
40
2
JBHT
62
2
PDCO
40
2
SWKS
36
-10
ISRG
70
-3
PPG
57
-3
NRG
62
-2
MAR
63
-2
LUV
45
-2
WAT
31
-2
AIZ
59
5
GRMN
71
22
NTAP
56
-4
RL
70
-3
PWR
60
-3
PYPL
41
-8
IVZ
52
-3
SLG
67
-3
SE
52
-2
BK
71
-3
RIG
40
2
JBHT
62
2
PDCO
40
2
SWKS
36
-10
ISRG
70
-3
PPG
57
-3
NRG
62
-2
MAR
63
-2
Financhill
Back

Molecular Templates 10K Form

Sell
11

MTEM
Molecular Templates

Last Price:
0.45
Seasonality Move:
-2.68%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MTEM News And Ratings

See the #1 stock for the next 7 days that we like better than MTEM

MTEM Financial Statistics

Sales & Book Value

Annual Sales: $52.63M
Cash Flow: $-5.86M
Price / Cash Flow: 0
Annual Sales: $1.08
Price / Book: 0.42

Profitability

EPS (TTM): -2.78000
Net Income (TTM): $-15.63M
Gross Margin: $12.5M
Return on Equity: -510.12%
Return on Assets: -46.29%

Molecular Templates Earnings Forecast

Key Molecular Templates Financial Ratios

  • The Gross Profit Margin over the past 3 years for MTEM is 100.04%.
  • The Selling, General & Administrative Expenses for MTEM have been equal to 35.91% of Gross Profit Margin.
  • The Research & Development expenses have been 92.87% of Revenue.
  • The Interest Expense is -32.67% of Operating Income.
  • The Net Earning history of MTEM is -15.44% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 13 years.

Molecular Templates Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MTEM
CUSIP: 608550
Website: mtem.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.56
Quick Ratio: 1.36

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MTEM Technical Analysis vs Fundamental Analysis

Sell
11
Molecular Templates (MTEM) is a Sell

Is Molecular Templates a Buy or a Sell?